Differential mitochondrial proteome analysis of human lung adenocarcinoma and normal bronchial epithelium cell lines using quantitative mass spectrometry

Thoracic Cancer

Volumn 4, Issue 4, 2013, Pages 373-379

  Zhang, Wei ^a   Li, Yanting ^b   Yang, Shuanying ^a   Li, Wei ^a   Ming, Zongjuan ^a   Zhang, Yuping ^a   Hou, Yanli ^a   Niu, Zequn ^a   Rong, Biaoxue ^a   Zhang, Xuede ^a   Liu, Xiaoli ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b People's Hospital of Tongchuan City   (China)

Author keywords

Adenocarcinoma; Expression; Mitochondrial proteins

Indexed keywords

HEAT SHOCK PROTEIN 90; MITOCHONDRIAL PROTEIN; ORNITHINE OXOACID AMINOTRANSFERASE; TUMOR MARKER; VIMENTIN;

ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; ISOLATION AND PURIFICATION; LUNG ADENOCARCINOMA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

EID: 84887005118     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12031     Document Type: Article

References (20)

1. Parkin DM. Global cancer statistics in the year 2000. (Published erratum appears in Lancet Oncol 2001; 2: 533-543.
2. Crocetti E, Paci E. Trends in lung adenocarcinoma incidence and survival. Lung Cancer 2002; 35: 215-216.
3. Han KQ, Huang G, Gao CF etal. Identification of lung cancer patients by serum protein profiling using surface enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 2008; 31: 133-139.
4. Mazzanti R, Giulivi C. Coordination of nuclear- and mitochondrial-DNA encoded proteins in cancer and normal colon tissues. Biochim Biophys Acta 2006; 1757: 618-623.
5. Jakupciak JP, Maragh S, Markowitz ME etal. Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer 2008; 8: 285.
6. Wu WW, Wang G, Baek SJ, Shen RF. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC MALDI TOF/TOF. J Proteome Res 2006; 5: 651-658.
7. Tao WA, Aebersold R. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr Opin Biotechnol 2003; 14: 110-118.
8. Carter MD, Southwick K, Lukov G, Willardson BM, Thulin CD. Identification of phosphorylation sites on phosducin-like protein by QTOF mass spectrometry. J Biomol Tech 2004; 15: 257-264.
9. Annunen-Rasila J, Ohlmeier S, Tuokko H, Veijola J, Majamaa K. Proteome and cytoskeleton responses in osteosarcoma cells with reduced OXPHOS activity. Proteomics 2007; 7: 2189-2200.
10. Münster PN, Srethapakdi M, Moasser MM, Rosen N. Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells. Cancer Res 2001; 61: 2945-2952.
11. Marmagne A, Rouet MA, Ferro M etal. Identification of new intrinsic proteins in Arabidopsis plasma membrane proteome. Mol Cell Proteomics 2004; 3: 675-691.
12. Prokisch H, Andreoli C, Ahting U etal. MitoP2: the mitochondrial proteome database-now including mouse data. Nucleic Acids Res 2006; 34 (Database issue): D705-D711.
13. Meisinger C, Sickmann A, Pfanner N. The mitochondrial proteome: from inventory to function. Cell 2008; 134 (1): 22-24.
14. Vora HH, Patel NA, Rajvik KN etal. Cytokeratin and vimentin expression in breast cancer. Int J Biol Markers 2009; 24: 38-46.
15. Colomiere M, Findlay J, Ackland L, Ahmed N. Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6betal integrin. Int J Biochem Cell Biol 2009; 41: 1034-1045.
16. Wei J, Xu G, Wu M etal. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 2008; 28 (1A): 327-334.
17. Yaziji H, Battifora H, Barry TS etal. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006; 19: 514-523.
18. Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer 2008; 99: 1476-1483.
19. Shirahata A, Sakata M, Sakuraba K etal. Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res 2009; 29: 279-281.
20. Kim KR, Choi HN, Lee HJ etal. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Oncol Rep 2007; 18: 825-832.